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Targeting DNA Bulged Microenvironments
with Synthetic Agents: Lessons from
a Natural Product
repeats in genomic DNA (e.g., myotonic dystrophy, Hun-
tington’s disease, Friederich’s ataxia, and fragile X syn-
drome). The unstable expansion of triplet repeats has
been attributed to reiterative synthesis due to slippage
and bulge formation in the newly formed DNA strand
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Clemson University base pairing involved at a bulged site, which requires a
unique wedge-shaped template.Clemson, South Carolina 29634
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to date originated from work on the enediyne naturalDepartment of Chemistry
Northeastern University product NCS-chrom [11]. This antitumor antibiotic typi-
cally undergoes cellular thiol addition and subsequentBoston, Massachusetts 02115
cycloaromatization to produce arene 2 (Figure 2), a pro-
cess that goes through a diyl radical intermediate, which
induces DNA strand scission, accounting for the biologi-Summary
cal activity of the agent. However, in the absence of
thiols, NCS-chrom undergoes an alternate general baseBulged regions of nucleic acids are important structural
motifs whose function has been linked to a number of catalyzed intramolecular cyclization to generate a spiro-
cyclic radical [12] that specifically cleaves bulged struc-key nuclear processes. Additionally, bulged intermedi-
ates have been implicated in the etiology of several tures (2–3 unpaired bases) in DNA and RNA [13-15].
In the absence of bulged DNA, NCS-chrom undergoesgenetic diseases and as targets for viral regulation.
Despite these obvious ramifications, few molecules spontaneous cyclization to form the spirocyclic arene 3
[16], an isostructural mimic of the DNA-cleaving species.are capable of selective binding to bulged sequences.
Prompted by the remarkable affinity of a natural prod- Though having minimal affinity for duplex DNA, 3 binds
specifically to a synthetic bulged DNA mimic at submi-uct metabolite, we have designed and prepared a se-
ries of readily accessible synthetic agents with selec- cromolar concentration [17], and solution phase NMR
studies have confirmed that the binding to the bulgetive bulge binding activity. Furthermore, by screening
a library of bulge-containing oligodeoxynucelotides, emanates from the unique molecular geometry of the
agent [18, 19]. A solution structure of the complex re-correlations between structure and affinity of the agents
can be drawn. In addition to potential applications in veals that the wedge-shaped molecule fits tightly in the
triangular prism pocket formed by the two looped-outmolecular biology, the availability of these spirocyclic
agents now opens the door for rational drug design. bases and the neighboring base pairs. In the bulge
pocket, the two ring systems of 3 mimic the geometry
of the helical bases with a twist angle of35 and stackIntroduction
with the base pairs above and below. Further, 3 is able
to induce bulge formation in otherwise unstructured re-Nucleic acids can have richly diverse structures, includ-
ing hairpins, knots, pseudoknots, triple helices, loops, gions of DNA [19]. The capacity for 3 to recognize bulges
stems specifically from the orientation of the ring sys-helical junctions, and bulges (Figure 1) [1]. Such bulged
structures in nucleic acids are of general biological sig- tems, transposed approximately 60by the spirolactone,
and the right-handed 35 twist of the molecule [18, 19].nificance [2]. They have been proposed as intermediates
in a multitude of processes including RNA splicing, Given the ramifications of such selective binding, this
has prompted effort to explore the specificity of bulgeframe-shift mutagenesis, intercalator-induced muta-
genesis, imperfect homologous recombination, as the bindings and, ultimately, design and synthesize readily
accessible bulge selective compounds.binding site for the coat protein of bacteriophage, and
in the ribosomal synthesizing machinery [3]. Bulges have
also been suggested as binding motifs for regulatory
Results and Discussionproteins involved with viral replication, including the TAR
region of HIV-1 [4-6]. Additionally, the etiology of at least
In order to survey the selectivity afforded by 3, we first12 human neurodegenerative genetic diseases has been
synthesized a variety of bulge- and hairpin-containingattributed to genetic variations in the lengths of triplet
oligodeoxyribonucleotides and associated control ele-
ments, and their putative fold patterns are shown in4 Correspondence: irving_goldberg@hms.harvard.edu (IHG), gr.jones@
Figure 3. Binding of 3 to these substrates was monitoredneu.edu (GBJ)
5 These authors contributed equally to this work. using fluorescence spectroscopy and provided striking
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synthesis. Further, we sought a more stable structure
than the lactone ring system. Based on these design
criteria, we instead reasoned that aldol product 4 (Figure
5), presumably available via ketoaldehyde 5, would be
an acceptable and readily available synthetic template
from which to build and install the aminosugar moiety,
having a predicted helical twist very similar to 3 and
providing the option for introduction of variable func-
tional groups [24].
Accordingly, a synthesis was devised and executedFigure 1. Assorted Nucleic Acid Conformations
(Figure 6). Diels-Alder cycloaddition of the cyclopenten-
one derived from in situ elimination of 6 with the diene
results (Table 1). As expected, affinity of 3 for a 12-mer 7 (derived from tetralone) gave cycloadduct 8. Oxidative
duplex sequence was low (entry 1), whereas affinity for cleavage to give 9 followed by aldol closure gave hydro-
a GT bulge containing counterpart was pronounced (en- xyketone 10 in good yield, isolated as a mixture of en-
try 2). Since the thermal stability of short duplexes is antiomers and accompanied by 25% of its exo isomer.
lower than that of their hairpin counterparts (Tm: entry The design criteria now called for addition of an
1, 44; entry 2, 32; entry 3, 65; entry 14, 80), we also aminosugar moiety. Though compound 10 could be sep-
assessed affinity for various hairpin-constrained ana- arated into its enantiomer pairs via chiral chromatogra-
logs containing 1, 2, and 3 base bulges (entries 3–6). phy, we elected to perform diastereomer separation fol-
Clearly, affinity for the 2 base bulge is optimal (entry 4), lowing glycosylation. An aminoglucose was selected as
and a panel of GT bulge containing 12-mers with differ- the pendant aminosugar group for reasons of simplicity
ent backbone sequences were then screened (entries and economy. Thus, -aminoglucose was converted to
7–12). As can be seen, striking differences in affinity activated derivative 11, subjected to acidic coupling
result from subtle modification in sequence, confirming with racemic 10 to give a mixture of diastereomers,
the high order of molecular recognition that 3 imparts which were separable by silica gel chromatography, and
[17]. In particular, replacement of the T•A base pair 3 then subjected to global deprotection to give enantio-
to the bulge site with an A•T base pair leads to marked mers 12 and 13. Though unfortunately not amenable to
loss in binding affinity (and in cleavage at the bulge [14]). X-ray analysis, structures 12 and 13 were fully assign-
Finally, the residual contribution of the hairpin se- able by COSY and CD-ORD spectroscopy (see SI) [25].
quences was assessed with additional controls (entries The derivatives were then screened alongside 3 for
13–15), confirming that the hairpin itself is a somewhat affinity to the battery of bulged and duplex sequences.
more accessible target than the corresponding duplex It became immediately apparent that the simple deriva-
(cf. entries 1, 14). tives were able to mimic the natural product-derived
The nanomolar affinity in many cases (entries 3, 4, 10, agent 3 effectively (Table 1). Enantiomers 12/13 had very
and 16) is remarkable, as is the preference for 2 base similar affinity to that of 3 for the 2 base bulge sequence
bulges [14, 17, 18], and bodes well for drug develop- (entry 2), and affinity for the duplex (entry 1) and unmodi-
ment. Since the results were so promising, we set about fied hairpin (entry 13) was low. Of significance, differen-
design of readily available mimics of 3 that might evolve tial affinity between 12 and 13 for selected bulged se-
into potential drug candidates. Based on analysis of the quences emerged, highlighting the bias that the
binding data for 3, NMR, and molecular modeling studies stereochemistry imparts (entries 3, 4, 5, and 7). Though 3
(PM3), it is clear that the key features responsible for 2 overall had gross affinity vastly higher to specific bulged
base-bulge binding are (i) the presence of two indepen- targets (entries 3, 4, 10, and 16), in several cases the
dent aromatic  systems, (ii) a spirocyclic ring junction synthetic agents showed improved affinity to 3 (entries
capable of offsetting the systems by 30–40, and (iii) a 5, 7, 8, and 9). Of note, variations within the bulged
pendant aminosugar moiety to enhance binding to the family are evident, which provide crucial information as
phosphate backbone at the bulged site (Figure 4). One to the architecture of the bulged target. Agent 3 shows
option would be to produce modified analogs of 3. How- poorer affinity than 12/13 for the single bulged sequence
ever, though several excellent approaches to NCS- (entry 5), presumably due to the steric bulk of the addi-
chrom and analogs have been reported [20-23], the tional functionality present. Likewise, a switch from py-
complexity of the syntheses effectively preclude use rimidine to purine base 3 to the bulge results in marked
reduction in affinity for 3 (entries 7, 8 versus 3), whereasof the natural product as a template, requiring scratch
Figure 2. Activation Cascade of Neocarzinostatin Chromophore in Presence or Absence of Thiol
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Figure 3. Synthetic Oligonucleotides
the relative effect on the synthetic agents was less pro- change on drug binding. Since efforts to interpret these
differences would be greatly assisted by X-ray data fornounced, implying subtle differences in binding orienta-
tion (cf. 12/13 entry 7). This observation is consistent the template, we pursued and were able to solve the
structure for 10 (Figure 7A). As can be seen, by virtuewith an earlier proposal, based on NMR studies [18,19],
that removal of the bulky cyclic carbonate moiety of 3 of the spirocyclic junction, the two aromatic frameworks
are clearly offset, presenting a helical twist (35) andwould obviate the discriminating effect of the sequence
establishing a wedge with a cone angle of 32. Super-
imposition of the three-dimensional structures of 3 and
Table 1. Dissociation Constants (M) of DNA Binding (Figure 3) 10 reveals their striking similarities (Figures 7B and 7C).
by the Drugs* This finding is of particular interest, since the structure
Entry Sequence Code 3 12 13 of 3 is NMR derived from its form in the complex with
bulged DNA and reflects binding pocket-induced con-1 DA12:DAc12 307 31.1 32.8
formational changes in which the two drug ring systems2 DA12:BA14 2.18 5.33 2.54
are brought closer together [19], whereas the structure3 HT3AGTT 0.033 1.34 0.46
4 HT4AGTT 0.026 1.21 0.53 of 10 is that found in the crystal, presumably reflecting
5 HT3AGT 20.6 9.71 1.75 crystal-induced compaction. A similar change may be
6 HT3AGCTT 0.71 5.74 3.04 expected to occur in the synthetic drug-bulged DNA
7 HT3AGTA 12.5 11.0 2.67
8 HT3TGTA 22.2 3.16 3.26
9 HT3GGTA 12.9 6.0 5.0
10 HT3GGTT 0.064 1.59 1.03
11 HT3GGTC 0.416 2.53 2.74
12 HT3CGTC 0.50 1.46 1.48
13 HT3TA 16.9 16.9 17.6
14 HT3AT 10 14.0 7.6
15 HT3AA 13.7 20.7 17.5
16 PEG4ATT 0.081 4.05 1.52
*Determined via emission spectra [exc 390 nm (3), 310 nm (12/13);
emm 400–600 nm (3), 350–550 nm (12/13)] using a slit width 2.0, and
a scan speed of 100 nm/min at 5C.
Figure 4. Structure-Affinity Correlation for NCSi-gb
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spirocyclic motif coupled to a pendant aminosugar
moiety. The availability of these agents has allowed
us to probe factors governing affinity to bulged se-
quences and the stability of the bulged motif as a
function of oligonucleotide structure. Our results indi-
cate that spirocyclic agents prefer a 2 base bulged
target on an oligodeoxynucelotide that contains a 3
base hairpin. Armed with these data, functional assays
can now be designed to allow us to explore the dynam-
Figure 5. Structure of 4  5 ics of bulge formation and the ramifications of bulge
binding in cellular events. With this work, the unsolved
problem of small molecule binding to an important
complex. The NMR-derived model of the ethylene glycol class of nucleic acid conformation has finally been
linked bulged sequence (Table 1, entry 16) [18,19] clearly addressed.
suggests that the prism-shaped binding pocket of the
bulge would be accessible to the template of 10, and Experimental Procedures
that further nonbonded interactions with the DNA would
be expected from the aminosugar moiety (Figure 4). The Preparation of Base Postactivated NCS-Chrom (NCSi-gb, 3)
NCS-chrom was isolated from the holoantibiotic NCS with 0.5 Mhigh affinity binding of 3 and the synthetic agents to
acetic acid in methanol and stored at –80C as described [16]. Gen-this sequence confirms this affinity (entry 16), and now
eral-base postactivated NCS chrom (NCSi-gb) was prepared by in-provides us with a topological model from which to
cubation of NCS-chrom (100 M) in 50 mM Tris-HCl (pH 8.5), 50%
design analogs. Further, it is expected that placement ethanol in the absence of DNA at 0C for 1 hr. Following lyophilization
of the aminosugar on the oxygen moiety of the 6-mem- of the reaction mixture, the dried sample was redissolved in 100
bered ring bicyclic system, akin to the naphthoate of the mM ammonium acetate at pH 4.0 and subjected to HPLC purification
on a reverse-phase C-18 column. Purification and isolation of 3natural product, will enhance bulge selectivity. Indeed,
was accomplished by using a linear gradient of 40%–65% solventgiven the potential for a combinatorial library approach
B/solvent A over a 40 min period (solvent A, aqueous 5 mM ammo-to synthesis, it is reasonable to expect that rationally
nium acetae [pH 4.0]; solvent B, methanolic 5 mM ammonium ace-
designed systems, including those with reactive func- tate [pH 4.0]; flow rate, 1 ml/min).
tionalities capable of alkylation or strand cleavage, can
now be designed to address specific bulged targets of 6,8,8a,9,15b,15c-Hexahydro-5H-Benzo[5,6]Indeno-
interest. [2,1-c]Phenanthren-9-One(8)
To a 250 ml round-bottom flask equipped with a reflux condenser
was added 3-bromobenz[f]indan-1-one (4.0 g, 15.38 mmol) [26],Significance
2-vinyl-3,4-dihydronapthalene (7) (3.27 g, 20.91 mmol) [27], and car-
bon tetrachloride (65 mL). The resulting solution was heated to reflux
Our work confirms that simple readily accessible syn- and Et3N (1.95 g, 19.23 mmol) in carbon tetrachloride (40 mL) was
thetic agents can show selectivity as bulge binders. added dropwise. The solution was refluxed for 3.0 hr and then
poured onto water (100 mL). The layers were separated and theThe prerequisite for binding is the presence of a fused
Figure 6. Intramolecular Aldol-Glycosylation Sequence for NCSi-gb Mimics
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Figure 7. Structures of Synthetic and Natural
Products
(A) ORTEP of spiroalcohol 10 showing hydro-
gen bonding.
(B and C) Overlapped structures of NCSi-gb
(blue) and synthesized spiroalcohol (red), re-
spectively.
NCSi-gb structure is from NMR structure of
NCSi-gb-bulge-DNA complex [18] and spiro-
alcohol structure is from X-ray crystallo-
graphic structure. Side view (A) and top view
(B) show similarity of twist angle (35) and
rise (3A˚) of the two ring systems of the two
structures.
aqueous layer was extracted with Et2O (3  100 mL). The combined (s, 1H), 7.95 (d, 1H, J 	 7.0 Hz), 7.56 (t, 2H, J 	 8.0 Hz), 7.42–7.52
(m, 3H), 7.37 (t, 1H, J 	 7.5 Hz), 7.21 (d, 1H, J 	 7.5 Hz), 6.9 (s, 1H),organic extracts were washed with 1% HCl (3  200 mL), saturated
NaHCO3 solution (2 200 mL), brine (3 200 mL), dried over MgSO4, 4.44 (dd, 1H, J 	 8.5 and 2.4 Hz), 3.76 (m, 2H), 3.45 (m, 1H), 3.21
(dd, 1H, J	 20 and 9.9 Hz), 2.6–2.72 (m, 1H), 2.2–2.4 (m, 1H), 1.9–2.04and concentrated in vacuo. The crude oil was purified by gradient
silica gel chromatography (0:100 to 3:100, Et2O:hexanes) to yield (m, 2H). 13C NMR 
 210.45, 203.99, 202.20, 145.00, 137.42, 136.58,
134.75, 132.95, 130.51, 129.82, 128.54, 128.23, 128.09, 127.85,the title compound (2.85 g, 55%) as a yellow solid, mp 148C–149C;
1H NMR 
 8.18 (s, 1H), 7.89 (m, 2H), 7.58 (d, 1H, J 	 7.44 Hz,), 7.44 127.56, 126.71, 124.26, 124.10, 50.78, 48.50, 48.32, 42.69, 40.63,
28.16; C25H20O3 requires: C, 81.50; H, 5.47. Found: C, 81.70; H, 5.35.(m, 3H), 7.34 (m, 2H), 7.02 (d, 1H, J 	 7.71 Hz), 5.68 (m, 1H), 4.16
(t, 1H, J 	 7.44 Hz), 3.96 (d, 1H, J 	 6.45 Hz), 3.17 (ddd, 1H, J 	
8.19, 8.19, 1.95 Hz), 2.98 (m, 1H), 2.35 (m, 1H), 2.22 (m, 1H) 2.10 (m, Spirocyclic Alcohol (10)
2H), 1.20 (m, 1H); 13C NMR 
 210.1, 147.5, 141.0, 139.8, 137.1, 136.5, Ketaldehyde (9) (1.2 g, 3.26 mmol) was dissolved in DMF (150 mL)
136.1, 132.1, 130.0, 129.0, 128.2, 128.08, 128.0, 126.9, 126.4, 126.1, the solution cooled to 0C for 10 min, then potassium carbonate
125.9, 122.8, 120.5, 48.8, 45.9, 42.3, 30.3, 29.1, 25.3; C25H20,O re- (1.35g, 9.78 mmol) was added, and the resulting mixture stirred at
quires: C, 89.25; H, 5.99; found: C, 89.32; H, 6.01. 0C for 10 min. The mixture was diluted with ether (150 mL), washed
with water (2  100 mL) and brine (100 mL), dried (Na2SO4), and
condensed in vacuo. Purification by SGC (100% ether) gave spiroal-2-[1-Oxo-3-(2-Oxo-1,2,3,4-Tetrahydro-1-Naphthalenyl)-2,3-
Dihydro-1H-Cyclopenta[b]Naphthalen-2-yl] Acetaldehyde(9) cohol 10 (0.85g, 70%) as a white solid mp 163C–164C; 1H NMR
(CDCl3, 300 MHz): 
 8.28 (s, 1H), 7.93 (m, 1H), 7.42–7.52 (m, 2H),Osmium tetroxide (5% aqueous solution, 1 mL) was added to a
mixture of 9 (1.35g, 4.018 mmol), 4-methylmorpholine N-oxide 7.1–7.4 (m, 2H), 7.2–7.3 (m, 1H), 6.87 (t, 1H, J 	 8.1 Hz), 6.55 (d, 1H,
J 	 8.1 Hz), 6.42 (s, 1H), 4.41 (d, 1H, J 	 1H, J 	 11.4 and 7.5 Hz),(0.68g, 5.02 mmol), THF (40 mL), acetone (8 mL), t-BuOH (5 mL),
and water (15 mL). The resulting mixture was stirred at room temper- 3.58 (ddd, 1H, J 	 16.5, 11.7, and 6.0 Hz), 3.36 (ddd, 1H, J 	 12.3,
9.0, and 0.9 Hz), 3.32 (ddd, 1H, J 	 15.9, 6.9, and 2.1), 3.2 (ddd, 1H,ature for 13 hr, then sodium dithionate (2 g) was added and stirring
continued for 15 min. The mixture was diluted with EtOAc (200 mL), J 	 16.0, 7.0, and 2.1 Hz), 3.06 (ddd, 1H, J 	 17.1, 5.7, and 2.7 Hz),
2.7–2.9 (m, 2H), 2.6 (ddd, 1H, J 	 12.3, 7.2, and 1.5 Hz). 13C NMR 
washed with water (2  50 mL), and brine (50 mL), dried (Na2SO4)
and condensed in vacuo. The resulting white residue was dissolved 213.95, 208.5, 145.04, 138.60, 136.87, 135.4, 135.0, 132.60, 130.31,
128.82, 128.71, 128.32, 128.20, 127.90, 127.1, 127.0, 126.90, 124.50,in THF (150 mL), then sodium periodate (2.2g, 10.28 mmol), and
H2SO4 (1.0 N, 1 mL) was added; the resulting heterogeneous mixture 75.30, 64.60, 48.0, 46.50, 38.60, 35.10, 29.00; C25H20O3 requires: C,
81.50; H, 5.47. found: C, 81.45; H, 5.51. Also isolated, exo isomerwas stirred for 4 hr. The mixture was diluted with ether (150 mL),
washed with water (2  100 mL), dried (Na2SO4), and condensed in (0.29 g, 24%); 1H NMR (CDCl3, 300 MHz): 
 8.27 (d, 1H, J 	 6 Hz),
7.95 (t, 1H, J 	 7.2 Hz), 7.71 (d, 1H, J 	 7.8 Hz), 7.56 (d, 1H, J 	vacuo to produce a residual solid, which was recrystallized from
chloroform/hexanes to give the title compound (1.40g, 95%) as a 7.2 Hz), 7.52–7.42 (m, 3H), 7.37 (d, 1H, J 	 7.2 Hz), 7.33–7.26 (m,
2H), 4.86 (dd, 1H, J 	 10 and 7.5 Hz), 4.32 (d, 1H, J 	 9.5 Hz), 3.33white solid mp 160C–162C; 1H NMR (CDCl3) 
 10.13 (s, 1H), 8.29
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(m, 1H), 2.84–2.68 (m, 3H), 2.45 (m, 2H), 2.15 (m, 1H); 13C NMR 
 Hz), 6.48 (bs, 1H), 6.40 (s,1H), 5.87 (d, 1H, J 	 8 Hz), 5.33 (t, 2H, J 	
211.8, 207.3, 145.0, 138.5, 138.5, 136.6, 136.3, 133.1, 130.7, 128.9, 10 Hz), 5.828 (s, 2H), 5.21 (d, 2H, J 	 10 Hz), 5.13 (t, 2H, J 	 10 Hz),
128.5, 127.9, 127.8, 127.4, 126.7, 126.5, 124.3, 123.1, 87.4, 64.2, 4.43 (m, 1H), 4.31 (m, 1H), 4.21 (m, 2H), 4.13 (m,2H), 4.04 (dt, 1H,
54.9, 48.3, 42.3, 43.1, 28.2; HRMS: calculated for C25H20O3 368.1412; J 	 10.5, 3.5 Hz), 3.65 (bs, 1H), 3.41(m, 1H), 3.20 (m, 1H), 3.07 (m,
found 368.1411. 1H), 2.73 (m, 1H), 2.59 (m, 1H), 2.05 (s, 3H), 2.04 (s, 3H), 1.95 (s, 3H);
13C NHR 
 211.6, 209.1, 171.0, 170.7, 169.6, 155.9, 146.5, 143.9,
141.5, 138.3, 136.9, 135.2, 132.6, 130.4, 129.2, 128.8, 128.3, 127.9,1,3,4,6- Tetra-O-Acetyl-2-Deoxy-2-(9-
127.5, 127.4, 127.3, 126.9, 126.8, 125.3, 124.3, 120.2, 103.0, 91.7,Fluorenylmethoxycarbonylamino)-D-Glucopyranose
71.1, 68.5, 67.9, 63.8, 62.2, 56.1, 50.7, 50.3, 47.3, 41.6, 33.0,31.1, 29.4,D-glucosamine hydrochloride (9.0 g, 41.77 mmol) and NaHCO3 (10
20.8; HRMS: calculated for C52 H47 N O12 877.3098; found 877.3099.g, 118.5 mmol) were dissolved in water (120 mL), and cooled to 0C.
A solution of 9-fluorenylmethyl chloroformate (6 g, 23.2 mmol) in Diastereomer B, isolated (23 mg, 10%) as a white solid (Rf 0.2 -
dioxane (60 mL) was added, and the mixture stirred for 1 hr. at room silica gel, 1:1 ethyl acetate/ hexanes); 1H NMR (CDCl3, 500 MHz): 

temperature. The resulting white precipitate was filtered and washed 8.31 (s, 1H), 7.97 (s, 1H), 7.77 (d, 2H, J 	 7.5 Hz), 7.47 (d, 2H, J 	
with water (3  25 mL), dried via anisotropy (toluene, 2  40 mL), 9.0 Hz), 7.41 (m, 5H), 7.30 (m,4H), 6.95 (bs, 1H), 6.77 (m, 1H), 6.37
and then dissolved in dry pyridine (80 mL). Acetic anhydride (80 mL) (s,1H), 5.8 (d, 1H, J 	 8 Hz), 5.06 (s, 1H), 4.93 (s, 1H), 4.48 (d, 2H,
was added and the mixture was stirred for 12 hr at 25C, poured J 	 6.5 Hz), 4.32 (t, 2H, J 	 3 Hz), 4.28-4.22 (m, 2H), 4.15 (m, 1H),
onto water/crushed ice (250 mL), and stirred vigorously to give a 4.07 (m, 1H), 3.99–3.93(m, 3H), 3.52 (t, 2H, J 	 10.5 Hz), 3.13 (m,
white precipitate. The precipitate was filtered and the residue 1H), 2.96 (m, 1H), 2.78–2.65 (m, 2H), 2.05 (s, 3H), 1.99 (s, 6H), 13C
washed with water (3  50 mL), 2% HCl (3  50 mL), saturated NMR 
 209.3, 207.3, 171.1, 170.9, 169.6, 155.2, 146.4, 143.9, 141.5,
NaHCO3 (1  50 mL), and water (1  50 mL), and then dried via 138.5, 136.8, 135.9, 132.6, 130.3, 128.9, 128.7, 128.6, 128.2, 128.1,
anisotropy (toluene, 2  50 mL) to yield of the title compound (12 127.9, 127.2, 126.7, 126.8, 125.4,.125.3, 125.2, 124.1, 120.2, 102.5,
g, 91%) as a white powder; 1H NMR (CDCl3, 300 MHz): 
 7.75 (d, 89.4, 71.9, 68.8, 66.9, 63.8, 62.4, 56.1, 51.3, 49.7, 47.0, 41.6, 33.3,
2H, J 	 7.5), 7.53 (t, 2H, J 	 8), 7.39 (t, 2H, J 	 7.5), 7.30 (d, 2H, 31.1, 29.6, 21.0, 20.8; HRMS: calculated for (MH): 877.3176; found
J 	 7), 6.2 (d, J 	 3.3,  H-1), 5.74 (d, J 	 8 Hz, -H1), 5.3–4.9 (m, 878.3176
2H), 4.45–4.95 (m, 7H), 2.20 (s, 1H), 2,09, 206, 2.04, 2.00 (4s,12H),
13C NMR 
 171.2,170.9, 169.6, 168.9, 155.9, 155.8, 143.8, 143.75,
141.5, 128.0, 127.3, 125.2, 120.3, 92.7, 91.0, 73.0, 72.5, 70.7, 69.9, Spirocylic Aminoglucose Conjugates (12 & 13)
68.1, 67.8, 67.4, 61.9, 61.8, 55.2, 47.2, 47.15, 21.2, 20.95, 20.8; HRMS: The individual, fully protected aminogluco-pyranosyl spiro com-
calculated. for C29 H31 N O11 569.1897; found 569.1895. pound diastereomer A (20 mg, 0.028 mmol) was dissolved in a solu-
tion of piperdine (10% in CH2Cl2, 0.5 mL) and stirred for 45 min
3,4,6-Tri-O-Acetyl-2-Deoxy-2-(9- at 25C. Volatiles were removed and the residue was dissolved in
Fluorenylmethoxycarbonylamino)--D- anhydrous methanol (3 mL) and cooled to 0C. A solution of NaOMe
Glucopyranosyltrichloroacetimidate(11) in methanol (0.5 ml of 1.0 M) was added and the reaction warmed
A solution of 1,3,4,6-tetra-O-acetyl-2-doexy-2-(9-fluorenylmethoxy- to 25C and stirred for an additional 1 hr. The reaction was quenched
carbonylamino)-D-glucopyranose (12 g, 21.1 mmol) in dry DMF (100 with water (0.5 mL), volatiles were removed, and then the crude
mL) was treated with hydrazinium acetate (2 g, 21.7 mmol) and residue purified via gradient radial chromatography (1.0 mm, 1:1
stirred for 50 min at 25C. It was then diluted with ethyl acetate (600 ethyl acetate/hexanes to 100% ethyl acetate) to yield 12 (6 mg,
mL), washed with brine (4  200 mL), and dried (MgSO4). Volatiles 50%) as a colorless oil. Similar treatment of diastereomer B gave
were removed in vacuo and the remaining oil was azeotroped with 13 (48%) as a colorless oil.
dry benzene (2 50 mL). The residual oil was dissolved in dry CH2Cl2 (12): 1H NMR(500MHz, CD3OD) 
 8.28 (s, 1H), 7.99 (m, 1H), 7.48(100 mL) then trichloroacetonitrile (15 mL, 103.9 mmol) and DBU
(m, 2H), 7.39 (m, 1H), 7.34 (d, J 	 7.5Hz, 1H), 7.12 (t, J 	 7.5 Hz,
(1.8 mL, 12 mmol) were added, and the mixture stirred at 25C for
1H), 6.58 (t, J 	 7.6 Hz, 1H), 6.50 (s, 1H), 6.16 (d, J 	 7.6 Hz, 1H),
45 min. The solution was condensed in vacuo, then the residual oil
4,62 (dd, J 	 10.5, 7.4 Hz, 1H), 4.35 (d, J 	 8.0 Hz, 1H), 4.00 (d, J 	
was purified by SGC (1:1 ethyl acetate/hexanes) to yield the title
7.9 Hz, 1H), 3.78 (dd, J 	 12.3, 2.4 Hz, 1H), 3.62 (dd, J 	 12.5, 5.5
compound (4.0 g 28%) as a pale yellow powder; 1H NMR (CDCl3, Hz, 1H), 3.46(dd, J 	 12.9, 8.6 Hz, 1H), 3.35 (ddd, J 	 12.5, 3.6 Hz,500 MHz): 
 8.80 (d,1H, J	 3.5 Hz), 7.75 (d, 2H, J 	 8 Hz), 7.51 (d,
1H), 3.20 (m, 2H), 3.02 (dd, J 	 10.5, 9.0, 1H), 2.96 (m, 1H), 2.83 (m,2H, J 	 7 Hz), 7.39 (t, 2H, J 	 7 Hz), 7.29 (t, 2H, J 	 8 Hz), 6.38
2H), 2.81 (ddd, J 	 15.5, 11.0, 1.6 Hz, 1H), 2.58 (ddd, J 	 13.0, 7.5,(d,1H, J 	 4 Hz), 5.45 (dd, 1H, J 	 9.5, 3), 5.35 (t,1H, J 	 10), 5.27
2.4Hz, 1H), 2.45 (dd, J 	 12.3, 8.1 Hz, 1H) ; 13C NMR (125.6 MHz,(t, 1H, J 	 9.5), 5.02 (d, 1H, J 	 9.5), 4.55 (ddd, 1H, J 	 11, 7.5, 2),
CD3OD) 
 214.5, 211.0, 147.4, 139.6, 137.7, 137.0, 135.8, 133.4, 130.7,4.42–4.10 (m, 5H), 2.09, 2.06, 2.05 (3s,9H),13C NMR 
 170.5, 169.1,
129.6, 129.3, 128.9, 128.7 127.7, 127.2, 126.2, 124.4, 103.4, 86.0,169.0, 160.2, 155.4, 150.7, 143.3, 141.1, 127.6, 126.9, 124.8, 119.9,
77.3, 76.4 70.8, 64.2, 61.8, 57.6, 51.3, 50.1, 41.3, 33.6, 29.0; HRMS:94.7, 70.2, 70.1, 67.3, 61.3, 60.3, 53.4, 46.8, 20.6; HRMS: calculated
calculated for C31 H31 N O7 529.2100; found 529.2105for C29 H29 Cl3 N2 O10 670.0888; found 670.0891.
(13): 1H NMR(500 MHz, CD3OD) 
 8.23 (s, 1H), 7.95 (m, 1H), 7.46
(m, 2H), 7.35 (m, 1H), 7.28 (d, J 	 7.5 Hz, 1H), 7.04 (t, J 	 7.5 Hz,Aminoglucose Coupling Reaction
1H), 6.53 (t, J 	 7.5 Hz, 1H), 6.48 (s, 1H), 6.16 (d, J 	 7.5 Hz, 1H),A suspension of spiroalcohol 10 (0.1 g, 0.27 mmol), trichloroacetimi-
4,67 (dd, J 	 10.0, 7.7 Hz, 1H), 4.40 (d, J 	 8.0 Hz, 1H), 4.22 (d, J 	date 11 (0.340 g, 0.51 mmol), and 3 A˚ molecular sieves (0.20 g) in
7.8 Hz, 1H), 3.48 (ddd, J 	 11.0, 9.5, 2.4 Hz, 1H), 3.40 (ddd, J 	CH2Cl2 (4.0 mL) was prepared in a 10 ml round-bottom flask and
11.0, 8.5, 3.4 Hz, 1H), 3.37 (m, 2H), 3.25(ddd, J 	 15.5, 6.0, 2.7 1H),the mixture was cooled to –30C under Ar. Triflic acid (0.1 mL, 0.33
3.15 (m, 2H), 3.00 (ddd, J 	 15.0, 11.5, 6.0, 1H), 2.95 (ddd, J 	 10.0,M in CH2Cl2) was added dropwise over 2 min. The resulting solution
4.8, 4.0 Hz, 1H), 2.76 (m, 2H), 2.60 (ddd, J 	 13.0, 7.5, 2.4 Hz, 1H),was warmed to 25C over 3 hr, then diluted to 50 ml with CH2Cl2,
2.46 (dd, J 	 12.0, 6.5 Hz, 1H) ; 13C NMR (125.6 MHz, CD3OD) 
filtered, and the filtrate washed with a saturated solution of sodium
214.7, 211.6, 147.3, 139.4, 137.8, 137.1, 135.8, 133.5, 130.7, 129.6,bicarbonate (2  15 mL). The organic phase was dried (MgSO4)
129.3, 128.7 128.4, 127.5, 127.3, 126.0, 124.4, 102.5, 85.5, 77.5, 76.4concentrated in vacuo, and the crude product purified by radial
70.9, 64.4, 61.3, 57.6, 51.2, 50.2, 41.0, 32.6, 29.2; HRMS: calculatedchromatography (silica gel, 1 mm, 30% ethyl acetate/hexanes) to
for C31 H31 N O7 Na 552.1998; found 552.1996give the coupling products corresponding to the 3,4,6-tri-O-acetyl-
2-deoxy-2-(9-fluorenylmethoxycarbonylamino)--D-glucopyranosyl
derivatives of 10 as individual diastereomers: diastereomer A, iso-
Supplemental Materiallated (40 mg, 17%) as a white solid (Rf 0.33 silica gel, 1:1 ethyl
Characterization data for 3, 12, 13 including COSY and CD analysis,acetate/ hexanes); 1H NMR (CDCl3, 500 MHz): 
 8.3 (s, 1H), 7.95 (s,
X-Ray coordinates for 10, and oligonucleotide preparation proce-1H), 7.775 (d, 2H, J 	 7.5 Hz), 7.62 (d, 2H, J 	 7.5 Hz), 7.57 (t, 2H,
dures and binding methods are available as supplemental material.J 	 8 Hz), 7.47 (m, 1H), 7.40 (t,2H, J 	 7.5 Hz), 7.35 (dd, 1H, J 	
7.5, 3 Hz), 7.31 (t, 2H, J 	 7.5 Hz), 7.20 (m, 1H), 7.04 (t, 1H, J 	 7.5 Please write to chembiol@cell.com for a PDF.
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